FindMyKOL

Nancy Wang, MD

Enriched profile

Neuro-oncologist · Massachusetts General Hospital

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Boston, MA · Northeast · United StatesSpecialtyHematology / OncologyFocusNeoplasm Metastasis+1
Active KOLFindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPayments2024–2025NIH fundingNone on fileWhy? →

Nancy Wang is Neuro-oncologist at Massachusetts General Hospital. ClinicalTrials.gov lists 4 registered studies with this person as an investigator.

Data verified 13 Nov 2026

Overview

Updated 17 Nov 2026

Nancy Wang, M.D., is Neuro-oncologist at Massachusetts General Hospital. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies.

  • Top research focus: Neoplasm Metastasis
  • 4 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neoplasm Metastasis3 trialsBrain Neoplasms2 trials

Research focus

OpenAlex concept fingerprint
Neoplasm MetastasisBrain Neoplasms

Drugs & molecules

across trials, industry payments and publications
Keytrudageneric · PembrolizumabClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Massachusetts General HospitalClinical trials4Industry payments—Telix PharmaceuticalsClinical trials—Industry payments2Merck Sharp & Dohme LLCClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
4clinical trials

Investigator role on registered studies.

View trials ↓
2companies · 2024–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Nov 2026

2 companies reported payments to CMS in program years 2024–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    100%
    Other antiepileptics57.7%
    Levetiracetam100%
    Part D≥12 patients
    Gabapentinoids42.3%
    Gabapentin100%
    Part D<11 patients
Where care is delivered (Part B)51.2% facility · 48.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 13 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncr.30911

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acsjournals.onlinelibrary.wiley.com ↗
  • Other

    health.usnews.com/doctors/nancy-wang-759229

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
  • Other

    pmc.ncbi.nlm.nih.gov/articles/PMC12979032

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
  • Other

    tlcr.amegroups.org/article/view/72041/html

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tlcr.amegroups.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    MPH

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →tlcr.amegroups.org ↗
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.